Publication:
Minimally invasive esophagectomy in the treatment of esophageal cancer.

dc.contributor.authorBjelović, Milos (56120871700)
dc.contributor.authorStojakov, Dejan (6507735868)
dc.contributor.authorSpica, Bratislav (14071827500)
dc.contributor.authorVelicković, Dejan (14072144000)
dc.contributor.authorGunjić, Dragan (55220962400)
dc.contributor.authorSkrobić, Ognjen (16234762800)
dc.contributor.authorDjurasić, Ljubomir (42561162200)
dc.contributor.authorGrujić, Danko (57197041806)
dc.contributor.authorPesko, Predrag (57204298089)
dc.date.accessioned2025-06-12T22:26:23Z
dc.date.available2025-06-12T22:26:23Z
dc.date.issued2011
dc.description.abstractIn the Western countries, the incidence of esophaeal carcinoma is 3-6 cases per 100,000 persons. g Despite tremendous success of other therapeutic options, surgical treatment still represents the best therapeutic option whenever possible. For the long period, debate has centered on which of the a vailable surgical procedures is superior-transhiatal or transthoracic esophagectomy. Minimally invasive esophagectomy (MIE) could offer both minimally invasive approach and proper mediastinal lymph node dissection. Minimally invasive esophagectomy is safe and adequate, but time consuming and technically demanding procedure. It is procedure reserved for the surgeons experienced in open esophagectomy for cancer, and specially trained in advanced minimally invasive procedures. Even in that case, learning curve is steep.
dc.identifier.urihttps://doi.org/10.2298/ACI1104027B
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84861175661&doi=10.2298%2fACI1104027B&partnerID=40&md5=6f7ad1f039d12b0059d59494f5ed94a5
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/9908
dc.titleMinimally invasive esophagectomy in the treatment of esophageal cancer.
dspace.entity.typePublication

Files